Literature DB >> 11395559

Nephrogenic adenoma of the prostatic urethra: a mimicker of prostate adenocarcinoma.

C H Allan1, J I Epstein.   

Abstract

Nephrogenic adenoma, thought to be a benign metaplastic response of the urothelium to injury, can rarely affect the prostatic urethra. Extension of small tubules of nephrogenic adenoma into the underlying prostatic fibromuscular stroma can lead to the misdiagnosis of prostatic adenocarcinoma in transurethral resection specimens and prostate biopsies. We reviewed 26 cases of nephrogenic adenoma involving the prostatic urethra, seen at The Johns Hopkins Hospital from 1990 to 1998, to evaluate the histologic features, which may better define this lesion. Immunohistochemical results were evaluated for cases where the lesion was present on deeper sections. Histologic patterns included the following: tubules in 96% (25 of 26), structures resembling vessels in 73% (19 of 26), cords and individual cells in 46% (12 of 26), papillary configurations in 19% (5 of 26), and signet ring cell-like tubules in 12% (3 of 26). Other features of nephrogenic adenoma, such as thyroidization, were identified in 38% (10 of 26), and peritubular sheaths were seen in 65% (17 of 26) of cases. Nucleoli were prominent in 54% (14 of 26), and no case had mitoses. In the region of nephrogenic adenoma, urothelium was noted in 69% (18 of 26); in 61% (11 of 18) it showed cuboidal metaplasia and 28% (5 of 18) showed squamous metaplasia. Extension of nephrogenic adenoma into muscle was observed in 77% (20 of 26) of cases, 75% (15 of 20) of which had identifiable urothelium overlying the lesion. Blue-tinged mucinous secretions were observed in 32% (8 of 25) of cases. Inflammation was found in all but one case. Nephrogenic adenomas were diffusely positive for 34betaE12 in 11% (1 of 9) of cases, focally positive in 44% (4 of 9), and negative in 44% (4 of 9). In 100% (9 of 9), cytokeratin 7 stains were positive. Focal prostate specific antigen and PSAP positivity were seen in 36% (4 of 11) and 50% (5 of 10) of nephrogenic adenoma cases, respectively. In conclusion, nephrogenic adenoma of the prostatic urethra can mimic prostate cancer because of: 1) the presence of tubules, cords, and signet ring-like tubules; 2) prominent nucleoli; 3) muscle involvement; 4) blue-tinged mucinous secretions; 5) focal prostate specific antigen and PSAP positivity; and 6) negative staining in some cases for 34betaE12. Features useful in the diagnosis of nephrogenic adenoma include the following: 1) distinctive nephrogenic patterns, such as papillary and "vascular," 2) adjacent urothelium, 3) thyroidization, 4) peritubular sheaths, 5) associated inflammation, and 6) positivity for cytokeratin 7 and, in some cases, 34betaE12.

Entities:  

Mesh:

Year:  2001        PMID: 11395559     DOI: 10.1097/00000478-200106000-00013

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

Review 1.  [Non-neoplastic alterations of the prostate. Why should pathologists know them?].

Authors:  A Erbersdobler
Journal:  Pathologe       Date:  2013-09       Impact factor: 1.011

2.  Nephrogenic adenoma of the urethra presenting as hematuria.

Authors:  G Krishna Kumar; R Malcomson; H Chandran
Journal:  Indian J Surg       Date:  2013-06-15       Impact factor: 0.656

3.  Renal-type clear cell carcinoma of the prostate: A case report.

Authors:  Qiulan Wang; Yongjie Xue
Journal:  Oncol Lett       Date:  2015-03-20       Impact factor: 2.967

4.  Nephrogenic adenoma of the ureter: case report.

Authors:  S U Bozkurt; I Erbarut; C Yazici; H Kaya; L Türkeri
Journal:  Int Urol Nephrol       Date:  2007       Impact factor: 2.370

5.  Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics.

Authors:  José I López; Marco Schiavo-Lena; Alexandra Corominas-Cishek; Adriana Yagüe; Kevin Bauleth; Rosa Guarch; Ondrej Hes; Regina Tardanico
Journal:  Virchows Arch       Date:  2013-10-19       Impact factor: 4.064

6.  Diagnostic utility of α-methylacyl CoA racemase (P504S) & HMWCK in morphologically difficult prostate cancer.

Authors:  K Kumaresan; Nandita Kakkar; Alka Verma; Arup Kumar Mandal; Shrawan Kumar Singh; Kusum Joshi
Journal:  Diagn Pathol       Date:  2010-12-22       Impact factor: 2.644

7.  Co-existence of mucin-producing urothelial-type adenocarcinoma of the prostate and inverted papilloma of the bladder.

Authors:  Xiao-Nan Mu; Si-Jun Wang; Zhi-Gang Sun; Min Zhang; Zhe Li; Long-Yang Zhang
Journal:  Contemp Oncol (Pozn)       Date:  2017-06-30

8.  The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer.

Authors:  Daijun Yang; Xiang Shi; Yu Lei; Xianrong Zhou; Qiuxiang Chen
Journal:  Oncol Lett       Date:  2020-05-21       Impact factor: 2.967

9.  Successful minimally-invasive management of a case of giant prostatic hypertrophy associated with recurrent nephrogenic adenoma of the prostate.

Authors:  Robert M Learney; Sachin Malde; Mark Downes; Nitin Shrotri
Journal:  BMC Urol       Date:  2013-04-08       Impact factor: 2.264

Review 10.  Nephrogenic Adenoma of the Urinary Bladder: A Review of the Literature.

Authors:  Anthony Kodzo-Grey Venyo
Journal:  Int Sch Res Notices       Date:  2015-02-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.